Windtree Therapeutics (WINT) Q4 2024 Earnings

27NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-211.5
-133.67
-55.85
21.98

Details

Expected EPS
-113.5
Actual EPS
-211.5
Surprise EPS
-98
Surprise Percent
+86.34%

Description

Windtree Therapeutics (WINT) has reported earnings of -211.5 per share for Q4 2024.

0 Comments

Share your thoughts